treosulfan sold brand name trecondi medication given people bone marrow transplant donor known allogeneic hematopoietic stem cell transplantation used conditioning treatment clear bone marrow make room transplanted bone marrow cells produce healthy blood used together another medicine called fludarabine adults children one month age blood cancers well adults severe disorders requiring bone marrow belongs family drugs called alkylating body treosulfan converted compounds called epoxides kill cells especially cells develop rapidly bone marrow cells attaching dna common side effects adults children infections nausea feeling sick stomatitis inflammation lining mouth vomiting diarrhoea abdominal pain belly tiredness febrile neutropenia low white blood cell counts fever high blood levels bilirubin breakdown product red blood cells also seen adults rash also affects treosulfan combination fludarabine indicated part conditioning treatment prior allogeneic haematopoietic stem cell transplantation allohsct adults malignant non malignant diseases children older one month malignant treosulfan approved use european union june two main studies showed treosulfan least effective busulfan another medicine used prepare patients haematopoietic stem cell one studies involving adults acute myeloid leukaemia blood cancer myelodysplastic syndromes conditions large numbers abnormal blood cells produced patients given treosulfan fludarabine successful transplant alive diseasefree years compared patients given busulfan additional study children blood cancers children given treosulfan fludarabine alive months february orphan designation granted european commission medac gesellschaft fuer klinische spezialpr√§parate mbh germany treosulfan conditioning treatment prior haematopoietic progenitor cell antineoplastic immunomodulatory drug article stub help wikipedia expanding httpsenwikipediaorgwikitreosulfan